Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Predictive Oncology Inc POAI

Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples... see more

Recent & Breaking News (NDAQ:POAI)

Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD

GlobeNewswire October 11, 2018

Precision Therapeutics’ Skyline Medical Division Signs International Distribution Agreement with India-based Prenit World

GlobeNewswire October 9, 2018

Precision Therapeutics Secures First STREAMWAY System Sale in Europe

GlobeNewswire September 27, 2018

Dr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, Joins Precision Therapeutics’ Scientific Advisory Board

GlobeNewswire September 25, 2018

Precision Therapeutics Bolsters Scientific Advisory Board with the Appointment of Dr. Paul Kornblith

GlobeNewswire September 13, 2018

Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board

GlobeNewswire September 11, 2018

Precision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine Sector

GlobeNewswire September 6, 2018

Precision Therapeutics Reports Second Quarter 2018 Financial Results

GlobeNewswire August 14, 2018

Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer Therapies

GlobeNewswire August 14, 2018

Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform

GlobeNewswire August 9, 2018

Precision Therapeutics to Hold Business Update Conference Call on August 14, 2018

GlobeNewswire August 8, 2018

Precision Therapeutics Making Rapid Progress with Both Personalized Medicine and Unique Medical Waste Disposal System

GlobeNewswire August 7, 2018

Precision Therapeutics Receives Approval of Delisting Request from German Stock Exchange

GlobeNewswire August 1, 2018

Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies

Accesswire July 17, 2018

Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System

GlobeNewswire July 12, 2018

Precision Therapeutics Signs Definitive Merger Agreement with Helomics Holding Corporation

GlobeNewswire June 28, 2018

Precision Therapeutics Launches New Website

GlobeNewswire May 31, 2018

Precision Therapeutics Reports First Quarter 2018 Financial Results

GlobeNewswire May 15, 2018

Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018

GlobeNewswire May 10, 2018

Precision Therapeutics to Hold Business Update Conference Call on May 15, 2018

GlobeNewswire May 8, 2018